Close Menu

Malcolm Maltby has become customer support manager for Farfield Sensors. He joins Farfield from Anachem, where he was responsible for maintenance and service of laboratory equipment. Also, Philip Onigman has joined SciPartners, Farfield Sensors’ US distributor, to help generate instrument sales in the US. He joins the company from Genzyme Transgenics, where he was director of marketing. Farfield, based in Salford, UK, sells instruments for the analysis of proteins and other molecules based on dual polarization interferometry.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The nonprofit Biden Cancer Initiative is suspending its operations, according to the Associated Press.

Researchers examine how white nationalists handle personal genetic ancestry results that conflict with their racist worldview, the New York Times reports.

NPR speaks with research participants before and after they learn their APOE E4 status, which affects their risk of developing Alzheimer's disease.

In PLOS this week: genetic characterization of Toxoplasma gondii strains, Crimean-Congo Hemorrhagic Fever Virus uncovered in Sudan, and more.

Jul
17
Sponsored by
GenomeWeb/ABRF

In this webinar, three experts will share advice on how to efficiently manage a mass spectrometry core lab while staying ahead of the technology curve.

Aug
22
Sponsored by
BC Platforms

This webinar will discuss how the Estonian Biobank, a cohort of more than 165,000 participants, is addressing industry challenges with data management and collaboration in the transition to precision medicine.